학술논문
Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09–09): a randomised, open-label, multicentre, phase 3 trial
Document Type
Article
Author
Döhner, Hartmut; Weber, Daniela; Krzykalla, Julia; Fiedler, Walter; Kühn, Michael W.M.; Schroeder, Thomas; Mayer, Karin; Lübbert, Michael; Wattad, Mohammad; Götze, Katharina; Fransecky, Lars; Koller, Elisabeth; Wulf, Gerald; Schleicher, Jan; Ringhoffer, Mark; Greil, Richard; Hertenstein, Bernd; Krauter, Jürgen; Martens, Uwe M.; Nachbaur, David; Samra, Maisun Abu; Machherndl-Spandl, Sigrid; Basara, Nadezda; Leis, Claudia; Schrade, Anika; Kapp-Schwoerer, Silke; Cocciardi, Sibylle; Bullinger, Lars; Thol, Felicitas; Heuser, Michael; Paschka, Peter; Gaidzik, Verena I.; Saadati, Maral; Benner, Axel; Schlenk, Richard F.; Döhner, Konstanze; Ganser, Arnold; Kühn, Michael W M; Wattad, Mohammed; Martens, Uwe M; Gaidzik, Verena I; Schlenk, Richard F
Source
In The Lancet Haematology July 2023 10(7):e495-e509
Subject
Language
ISSN
2352-3026